National Center for Advancing Translational Sciences at SfN 2026

Nov 14–18, 2026 Washington, DC ~21k attendees Website

National Center for Advancing Translational Sciences brings 3 presentations to SfN 2026 in Washington. Its SfN 2026 presentations centre on human stem cell models of neuronal development, Parkinsonian toxicants, and treatments for opioid use disorder. One thread examines how small molecules steer human stem cells toward cortico-thalamic or hypothalamic neuronal fates.

Organization	SfN 2026 Attendance
National Center for Advancing Translational Sciences Rockville, MD
ncats.nih.gov Government agencies U.S. federal biomedical research agency within the National Institutes of Health, based in Rockville, Maryland.	Talk Sun Nov 15 8:30–8:45am Part of Session NANO06: Emerging Approaches to Study Human Development and Disease In Vitro Small Molecule Modulation of Lineage Bifurcation Between Cortico-Thalamic and Hypothalamic Neuronal Fates from Human Pluripotent Stem Cells WCC Rm 146C Poster Wed Nov 18 8am–noon Part of Session PSTR305: Parkinson's Disease: Cellular Mechanisms Mechanistic characterization of novel potential Parkinsonian toxicants Identified through qHigh-Throughput Screening of MT1G expression WCC Halls A-C · Board V6 Poster Wed Nov 18 1–5pm Part of Session PSTR375: Drug Discovery and Novel Therapeutics for Substance Use Disorders Developing the dopamine D3 receptor (D3R) antagonist, (R)-VK4-116, as a non-opioid medication for the treatment of opioid use disorder WCC Halls A-C · Board KK1

Organization

SfN 2026 Attendance

National Center for Advancing Translational Sciences

Rockville, MD

ncats.nih.gov

Government agencies

U.S. federal biomedical research agency within the National Institutes of Health, based in Rockville, Maryland.

Talk

Sun Nov 15
8:30–8:45am

Part of Session NANO06: Emerging Approaches to Study Human Development and Disease In Vitro

Small Molecule Modulation of Lineage Bifurcation Between Cortico-Thalamic and Hypothalamic Neuronal Fates from Human Pluripotent Stem Cells

WCC Rm 146C

Poster

Wed Nov 18
8am–noon

Part of Session PSTR305: Parkinson's Disease: Cellular Mechanisms

Mechanistic characterization of novel potential Parkinsonian toxicants Identified through qHigh-Throughput Screening of MT1G expression

WCC Halls A-C · Board V6

Poster

Wed Nov 18
1–5pm

Part of Session PSTR375: Drug Discovery and Novel Therapeutics for Substance Use Disorders

Developing the dopamine D3 receptor (D3R) antagonist, (R)-VK4-116, as a non-opioid medication for the treatment of opioid use disorder

WCC Halls A-C · Board KK1

Instantly find 20 buyers from National Center for Advancing Translational Sciences

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Society for Neuroscience. Organization details are derived from SfN’s published exhibitor list, its Neuroscience Meeting Planner and each organization’s own website. Submit a correction